These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22973724)

  • 21. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers.
    Vignot S; Besse B; André F; Spano JP; Soria JC
    Crit Rev Oncol Hematol; 2012 Dec; 84(3):301-13. PubMed ID: 22710198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research and development for cancer biomarker].
    Nakagawa H
    Nihon Rinsho; 2012 May; 70(5):743-7. PubMed ID: 22619995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L; Lind MJ; Welham KJ; Cawkwell L;
    Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T; Carbone DP
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oncoproteomics in the personalized management of cancer.
    Jain KK
    Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers: an overview for oncology nurses.
    Richmond ES; Dunn D
    Semin Oncol Nurs; 2012 May; 28(2):87-92. PubMed ID: 22542315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational studies for target-based drugs.
    Nishio K; Arao T; Shimoyama T; Fujiwara Y; Tamura T; Saijo N
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():90-3. PubMed ID: 16273363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
    Issaq HJ; Waybright TJ; Veenstra TD
    Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel biomarkers of metastatic cancer.
    Dawood S
    Expert Rev Mol Diagn; 2010 Jul; 10(5):581-90. PubMed ID: 20629508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in oncoproteomics.
    Jain KK
    Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques.
    Sullivan CA; Chung GG
    Clin Colorectal Cancer; 2008 May; 7(3):172-7. PubMed ID: 18621634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum biomarker profiling in cancer studies: a question of standardisation?
    Matharoo-Ball B; Miles AK; Creaser CS; Ball G; Rees R
    Vet Comp Oncol; 2008 Dec; 6(4):224-47. PubMed ID: 19178682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.